AC
YDESW

Aristeia Capital’s YD Bio Ltd Warrants YDESW Stock Holding History

Aristeia Capital’s Portfolio YDESW Stock Details YDESW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37K Buy
63,274
+50,000
+377% +$42.5K ﹤0.01% 613
2025
Q4 		$13.6K Hold
13,274
– – ﹤0.01% 571
2025
Q3 		$27.5K Buy
+13,274
New +$23.2K ﹤0.01% 487

Other funds holding YDESW

CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
TNA
True North Advisors Dallas, Texas $877M AUM 13.86% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $9.2B AUM 23.26% 1-Year Est. Return
SSG
Summit Securities Group New York $810M AUM 27.35% 1-Year Est. Return

Aristeia Capital's YDESW Position: Q1 2026 in Review

Aristeia Capital increased its YD Bio Ltd Warrants (YDESW) stake by 377% in Q1 2026, buying an estimated $42.5K and bringing the position to 63,274 shares worth $37K. The position accounts for ﹤0.01% of the portfolio, ranked #613.

Aristeia Capital first reported a position in YDESW in Q3 2025 and has held it in 3 quarters since. 9 funds tracked by Wall St. Rank hold YDESW as of Q1 2026.

  • Aristeia Capital held 63,274 shares of YD Bio Ltd Warrants worth $37K as of Q1 2026.
  • Aristeia Capital bought 50,000 YD Bio Ltd Warrants shares in Q1 2026, an estimated $42.5K.
  • YD Bio Ltd Warrants made up ﹤0.01% of Aristeia Capital's portfolio in Q1 2026, its #613 holding.
  • Aristeia Capital first reported a position in YD Bio Ltd Warrants in Q3 2025 and has held it in 3 quarters since.
  • 9 funds tracked by Wall St. Rank held YD Bio Ltd Warrants as of Q1 2026.

Based on Aristeia Capital's 13F filing for Q1 2026, filed 15 May 2026.